Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients

No effect of apolipoprotein E polymorphism

M. Wauters, Robert Considine, A. Lofgren, C. Van Broeckhoven, C. Van der Auwera J.-, I. De Leeuw, L. Van Gaal

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Leptin levels have been shown previously to be associated with anthropometric parameters such as the body mass index (BMI), total body fat, and subcutaneous fat. Since apolipoprotein E (apoE) polymorphism is known to be a genetic marker affecting the relationship between certain anthropometric and metabolic parameters, we evaluated whether the leptin level and/or associations between the leptin level and body composition in non-insulin- dependent diabetic patients could be determined by apoE polymorphism. In 171 type 2 diabetic patients (105 male and 66 female), body composition (BMI, waist to hip ratio [WHR], fat mass, and visceral fat) was measured and fasting blood samples were obtained to determine the apoE genotype, leptin, glucose, and insulin levels, and the lipid profile. The mean leptin level for the whole group was 11.7 ± 9.3 ng/mL, with a significant difference (P <.001) between men (7.1 ± 4.9 ng/mL) and women (19.0 ± 10.1 ng/mL). No difference was found for leptin levels or anthropometric variables between the 3 different apoE genotypes (E3/E3 homozygotes, E2 carriers, and E4 carriers). Only low-density lipoprotein (LDL) cholesterol was significantly different between the 3 apoE subgroups. The correlations of leptin with anthropometric variables, especially visceral fat, tended to be different between the 3 apoE groups, but this was not independent and no effect was found after controlling for the other parameters in the model. A multiple regression model containing gender, subcutaneous fat, fasting glucose, triglycerides, and high-density lipoprotein (HDL) cholesterol explained 81% of the variance in leptin levels. We conclude that apoE polymorphism has no effect on the leptin level or its associations with other anthropometric and metabolic parameters. Copyright (C) 2000 by W.B. Saunders Company.

Original languageEnglish (US)
Pages (from-to)724-730
Number of pages7
JournalMetabolism: Clinical and Experimental
Volume49
Issue number6
StatePublished - 2000

Fingerprint

Body Fat Distribution
Apolipoproteins E
Leptin
Apolipoprotein E3
Intra-Abdominal Fat
Subcutaneous Fat
Body Composition
Fasting
Body Mass Index
Genotype
Glucose
Waist-Hip Ratio
Homozygote
Genetic Markers
LDL Cholesterol
HDL Cholesterol
Adipose Tissue
Triglycerides
Fats
Insulin

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients : No effect of apolipoprotein E polymorphism. / Wauters, M.; Considine, Robert; Lofgren, A.; Van Broeckhoven, C.; Van der Auwera J.-, C.; De Leeuw, I.; Van Gaal, L.

In: Metabolism: Clinical and Experimental, Vol. 49, No. 6, 2000, p. 724-730.

Research output: Contribution to journalArticle

Wauters, M. ; Considine, Robert ; Lofgren, A. ; Van Broeckhoven, C. ; Van der Auwera J.-, C. ; De Leeuw, I. ; Van Gaal, L. / Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients : No effect of apolipoprotein E polymorphism. In: Metabolism: Clinical and Experimental. 2000 ; Vol. 49, No. 6. pp. 724-730.
@article{6c89d7d7172d47f6944999d4ec73ed8e,
title = "Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients: No effect of apolipoprotein E polymorphism",
abstract = "Leptin levels have been shown previously to be associated with anthropometric parameters such as the body mass index (BMI), total body fat, and subcutaneous fat. Since apolipoprotein E (apoE) polymorphism is known to be a genetic marker affecting the relationship between certain anthropometric and metabolic parameters, we evaluated whether the leptin level and/or associations between the leptin level and body composition in non-insulin- dependent diabetic patients could be determined by apoE polymorphism. In 171 type 2 diabetic patients (105 male and 66 female), body composition (BMI, waist to hip ratio [WHR], fat mass, and visceral fat) was measured and fasting blood samples were obtained to determine the apoE genotype, leptin, glucose, and insulin levels, and the lipid profile. The mean leptin level for the whole group was 11.7 ± 9.3 ng/mL, with a significant difference (P <.001) between men (7.1 ± 4.9 ng/mL) and women (19.0 ± 10.1 ng/mL). No difference was found for leptin levels or anthropometric variables between the 3 different apoE genotypes (E3/E3 homozygotes, E2 carriers, and E4 carriers). Only low-density lipoprotein (LDL) cholesterol was significantly different between the 3 apoE subgroups. The correlations of leptin with anthropometric variables, especially visceral fat, tended to be different between the 3 apoE groups, but this was not independent and no effect was found after controlling for the other parameters in the model. A multiple regression model containing gender, subcutaneous fat, fasting glucose, triglycerides, and high-density lipoprotein (HDL) cholesterol explained 81{\%} of the variance in leptin levels. We conclude that apoE polymorphism has no effect on the leptin level or its associations with other anthropometric and metabolic parameters. Copyright (C) 2000 by W.B. Saunders Company.",
author = "M. Wauters and Robert Considine and A. Lofgren and {Van Broeckhoven}, C. and {Van der Auwera J.-}, C. and {De Leeuw}, I. and {Van Gaal}, L.",
year = "2000",
language = "English (US)",
volume = "49",
pages = "724--730",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Associations of leptin with body fat distribution and metabolic parameters in non-insulin-dependent diabetic patients

T2 - No effect of apolipoprotein E polymorphism

AU - Wauters, M.

AU - Considine, Robert

AU - Lofgren, A.

AU - Van Broeckhoven, C.

AU - Van der Auwera J.-, C.

AU - De Leeuw, I.

AU - Van Gaal, L.

PY - 2000

Y1 - 2000

N2 - Leptin levels have been shown previously to be associated with anthropometric parameters such as the body mass index (BMI), total body fat, and subcutaneous fat. Since apolipoprotein E (apoE) polymorphism is known to be a genetic marker affecting the relationship between certain anthropometric and metabolic parameters, we evaluated whether the leptin level and/or associations between the leptin level and body composition in non-insulin- dependent diabetic patients could be determined by apoE polymorphism. In 171 type 2 diabetic patients (105 male and 66 female), body composition (BMI, waist to hip ratio [WHR], fat mass, and visceral fat) was measured and fasting blood samples were obtained to determine the apoE genotype, leptin, glucose, and insulin levels, and the lipid profile. The mean leptin level for the whole group was 11.7 ± 9.3 ng/mL, with a significant difference (P <.001) between men (7.1 ± 4.9 ng/mL) and women (19.0 ± 10.1 ng/mL). No difference was found for leptin levels or anthropometric variables between the 3 different apoE genotypes (E3/E3 homozygotes, E2 carriers, and E4 carriers). Only low-density lipoprotein (LDL) cholesterol was significantly different between the 3 apoE subgroups. The correlations of leptin with anthropometric variables, especially visceral fat, tended to be different between the 3 apoE groups, but this was not independent and no effect was found after controlling for the other parameters in the model. A multiple regression model containing gender, subcutaneous fat, fasting glucose, triglycerides, and high-density lipoprotein (HDL) cholesterol explained 81% of the variance in leptin levels. We conclude that apoE polymorphism has no effect on the leptin level or its associations with other anthropometric and metabolic parameters. Copyright (C) 2000 by W.B. Saunders Company.

AB - Leptin levels have been shown previously to be associated with anthropometric parameters such as the body mass index (BMI), total body fat, and subcutaneous fat. Since apolipoprotein E (apoE) polymorphism is known to be a genetic marker affecting the relationship between certain anthropometric and metabolic parameters, we evaluated whether the leptin level and/or associations between the leptin level and body composition in non-insulin- dependent diabetic patients could be determined by apoE polymorphism. In 171 type 2 diabetic patients (105 male and 66 female), body composition (BMI, waist to hip ratio [WHR], fat mass, and visceral fat) was measured and fasting blood samples were obtained to determine the apoE genotype, leptin, glucose, and insulin levels, and the lipid profile. The mean leptin level for the whole group was 11.7 ± 9.3 ng/mL, with a significant difference (P <.001) between men (7.1 ± 4.9 ng/mL) and women (19.0 ± 10.1 ng/mL). No difference was found for leptin levels or anthropometric variables between the 3 different apoE genotypes (E3/E3 homozygotes, E2 carriers, and E4 carriers). Only low-density lipoprotein (LDL) cholesterol was significantly different between the 3 apoE subgroups. The correlations of leptin with anthropometric variables, especially visceral fat, tended to be different between the 3 apoE groups, but this was not independent and no effect was found after controlling for the other parameters in the model. A multiple regression model containing gender, subcutaneous fat, fasting glucose, triglycerides, and high-density lipoprotein (HDL) cholesterol explained 81% of the variance in leptin levels. We conclude that apoE polymorphism has no effect on the leptin level or its associations with other anthropometric and metabolic parameters. Copyright (C) 2000 by W.B. Saunders Company.

UR - http://www.scopus.com/inward/record.url?scp=0034042572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034042572&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 724

EP - 730

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 6

ER -